Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating transplant rejection with silent Fc variants of anti-CD40 antibodies

Method of treating transplant rejection with silent Fc variants of anti-CD40 antibodies

US Patent 11124578 · Granted Sep 21, 2021

Estimated economic value: $16,722,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa2025
Anti-CD40 antibodies for use in treatment of Sjögren's syndrome2024
Anti-BAFFR antibody formulations and methods of use thereof2024
Anti-CD40 antibodies for use in prevention of graft rejection2023
Anti-BAFFR antibody formulations and methods of use thereof2021
Production of oversized adeno-associated vectors2020
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2017
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2017
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2017